1. Pfizer, Moderna COVID vaccines could reach all Americans by June 2021 — FDA approves fewer generics in FY2020, ending record streak — Planes, trucks, and ultracold boxes: Pfizer preps massive COVID-19 vaccine distribution effort — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

i3 being sold?

Discussion in 'i3 Research' started by Anonymous, Nov 5, 2010 at 12:34 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    heard i3 is being sold....any truth to this? if so, to whom? perhaps the C company that was interested a few years back?
     

  2. Anonymous

    Anonymous Guest

    what is the c company??
     
  3. Anonymous

    Anonymous Guest

    I heard INC was interested..
     
  4. Anonymous

    Anonymous Guest

    Yes being sold announcement should be made this week and its not to INC............
     
  5. Anonymous

    Anonymous Guest

    probably some private capital firm....seems to be the "in" thing with these sweater vest wearing, microsoft excel using, inspirational wall art silly geese......pharmanet, INC, PRA, RPS, and others are recently bought by private equity.....hopefully i3 is not the next to fall.....
     
  6. Anonymous

    Anonymous Guest

    SOLD
    Inventive Health
    Glen is the new CEO
     
  7. Anonymous

    Anonymous Guest

    So will Glen run the new company like i3 if he's CEO? If inventive bought i3, would Glen have to follow Inventive's processes?
     
  8. Anonymous

    Anonymous Guest

    So, is this all of i3 - including statprobe? Will there be layoffs or do you all know yet? What about the huge Lilly contract i3 secured in the Fall 2010? What about Gregg? I know folks at i3. Used to really like the company. Hears hoping things work out for you all.
     
  9. Anonymous

    Anonymous Guest

    I3 complete is been sold?.. what about I3 Research?? will it be any firing??
     
  10. Anonymous

    Anonymous Guest

    if i3 had three rounds of layoffs in 2010 and the ceo is going to be the ceo of inventive that doesn't sound good for inventive or i3 employees. what are they thinking?
     
  11. Anonymous

    Anonymous Guest

    not all of i3 just poor performing cro part etc. andy s got sick of glenn b and rumor is he will be gone within 6 months. also other retained parts will have problem as now competing with merck-medco which bought ubc so hecon/epi at i3 is screwed.
     
  12. Anonymous

    Anonymous Guest

    Sale was pharma resourcing (profitable), statprobe (profitable) and the CRO (basket case). Andy S wanted to keep innovus and pharma informatics as they are a good match for Ingenix and have footprint outside of USA. Glenn went with the sale, who knows how long he'll stay. Ingenix have been paring down staff and reorganising key shared functions to get this sale ready for a year.
     
  13. Anonymous

    Anonymous Guest

    Are the CRO employees next to go?
     
  14. Anonymous

    Anonymous Guest

    No jobs will be lost. Inventiv is SOLID and will help i3 get back on board.
     
  15. Anonymous

    Anonymous Guest

  16. Anonymous

    Anonymous Guest

    glad the jobs are safe. What about the employees?
     
  17. Anonymous

    Anonymous Guest

    the jobs are not safe. never have been before sale with 4 down-sizings and are not now with sale. Word is that reductions of 30-35% in next year.
     
  18. Anonymous

    Anonymous Guest

    Is drug safety first to go?
     
  19. Anonymous

    Anonymous Guest

    If another company is buying them, how can they say they're going to downsize? Isn't that up to the new company that purchases them?
     
  20. Anonymous

    Anonymous Guest

    Do you seriously think that Inventiv is not down-sizing the CRO portion? They can't compete well with stand-alone CROs that are growing, having clin pharm units, partnership deals with many major pharma companies, already expanded in to China with real resources before i3 ever got off its butt. More layoffs to come; especially in medical and scientific affairs, and project management